Implementing guidelines to prevent cancer associated thrombosis: how can we do better?
Steven Ades, Chris E. Holmes
Abstract
Societal guidelines addressing the prevention of venous thromboembolism (VTE) in ambulatory patients with cancer are numerous [1]. The need for guidelines is driven by an increased risk of VTE among patients with cancer (with 70% to 80% of events occurring in the outpatient setting) and the high cost of VTE management in this patient population, including decreased quality of life, increased bleeding, and early mortality in some cases [2]. Importantly, the incidence of VTE in patients with cancer is increasing in parallel with the increased number of patients living with cancer [3].
Topics & Concepts
MedicineAmbulatoryVenous thromboembolismCancerIncidence (geometry)Intensive care medicineThrombosisPopulationQuality of life (healthcare)Venous thrombosisEmergency medicineInternal medicineEnvironmental healthNursingPhysicsOpticsVenous Thromboembolism Diagnosis and ManagementCentral Venous Catheters and HemodialysisChemotherapy-induced cardiotoxicity and mitigation